Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

Within the 2011 to 2016 NHANES cohort of the U.S. population, a notable inverse association was detected between serum vitamin D concentrations and sleep disorders (β = − 3.81, 95% CI: − 6.10 to − 1.52, p = 0.003).

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Genetic instrumental-variable study.

Genetic instrumental-variable study

Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Serum vitamin D concentrations and sleep disorders: insights from NHANES 2011 to 2016 and Mendelian Randomization analysis

Source: Article title.

The average serum vitamin D level among participants was 61.80 nmol/L (Table ).

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Full studies

Serum vitamin D concentrations and sleep disorders: insights from NHANES 2011 to 2016 and Mendelian Randomization analysis

Genetic instrumental-variable study · Sleep & Breathing = Schlaf & Atmung · 2024

Original publication title

Serum vitamin D concentrations and sleep disorders: insights from NHANES 2011 to 2016 and Mendelian Randomization analysis

Junjie Jiang; Hanyu Tan; Zhongfang Xia; Jun Li; Shuang Zhou; Tao Huang

© The Author(s) 2024

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

Authors’ conclusion

Collectively, the findings from this study demonstrate a significant negative correlation between serum vitamin D deficiency and sleep disturbances, as evidenced through both cross-sectional and Mendelian Randomization (MR) analyses. These insights suggest that healthcare professionals should be more vigilant regarding sleep disorders in patients, highlighting the necessity for further comprehensive research to confirm these results and to understand the underlying mechanisms of this association.

An extract from the source publication. Read it in context.

At a glance

Abstract: What objectives does the paper state?

This investigation seeks to examine the association between serum vitamin D concentrations and the prevalence of sleep disorders, additionally elucidating the causal relationship via Mendelian Randomization (MR) analysis.

Source: Objective

Study methods

What methods does the paper describe?

Data source

The investigation utilizes data from three successive iterations of the National Health and Nutrition Examination Survey (NHANES), encompassing the timeframes of 2011 to 2012, 2013 to 2014, and 2015 to 2016. The survey encompassed questionnaires, examination data, and laboratory test results and is conducted with the approval of the National Center for Health Statistics (NCHS) Institutional Review Board. Biennial data releases ensure up-to-date information, and participation is contingent on written informed consent from all respondents.

Between 2011 and 2016, the NHANES survey engaged 29,902 participants. Our analysis excluded individuals based on specific criteria: those not within the 20 to 50 age range (20,861 participants), absence of data on 25-hydroxyvitamin D3 (2,389 participants) and other related vitamin D metrics (795 participants), and incomplete information on sleep disorders (944 participants). This resulted in a final sample of 4913 for our study. Figure 1 depicts the selection process.

Fig. 1

Flowchart of participants included in analyses

Figure image at the original source: open the original paper. This file is not included in this text import.

Sleep disorders

Data on sleep disorders were gathered from participants’ responses to a specific query: “Over the last 2 weeks, how often have you been bothered by the following problems: trouble falling or staying asleep, or sleeping too much?” A sleep disorder was identified if the answer was “more than half the days” or “nearly every day.” Conversely, responses of “several days” or “not at all” indicated the absence of a sleep disorder.

Laboratory measures

Ultra-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) was employed for the quantification of 25-hydroxyvitamin D in human serum. The lower limit of detection (LLOD) for 25-hydroxyvitamin D3 was established at 2.23 nmol/L. The comprehensive methodology for this analytical procedure is extensively delineated in other scholarly publications. For values below the LLOD, the calculation employed was the square root of LLOD divided by two (LLOD/√2).

Covariates

Continuous variables in the study encompassed age, body mass index (BMI), along with systolic and diastolic blood pressure. The study categorized variables as follows: Populations or ethnic groups are categorized into four distinct segments: Mexican Americans, non-Hispanic whites, non-Hispanic blacks, and other races. Gender included male and female. Educational attainment is categorized as either incomplete or complete with respect to upper secondary education. In categorizing marital status, the amalgamation of marriage and cohabitation into a single category is contrasted with the distinct classification of being single, divorced, widowed, or separated.

Alcoholism, smoking, poverty-to-income ratio, high blood pressure, and diabetes are categorically classified as “yes” or “no.” Participants’ ages were classified into three categories: 20 to 29, 30 to 39, and 40 to 50. Obesity was defined as a BMI ≥ 30 according to Centers for Disease Control and Prevention (CDC) guidelines. Alcohol status was ascertained based on participants’ responses to the query, which inquired whether they had consumed 12 or more alcoholic drinks in the preceding year. Participants who responded affirmatively were classified as alcohol users, and conversely for those who answered negatively.

Smoking status was assessed using the question: Do you now smoke cigarettes, with respondents answering “Every day” or “Some days” being considered as current smokers. The poverty-income ratio was delineated as ≥ 1.3 for non-poverty status and < 1.3 for poverty status. Each participant had three to four consecutive blood pressure levels taken. Systolic (SBP) and diastolic blood pressure (DBP) values were computed as the average of all extant readings. Hypertension was identified when SBP was ≥ 140 mmHg and DBP was ≥ 90 mmHg [16, 17].

Source: Materials and methods Source: Materials and methods Source: Materials and methods Source: Materials and methods

Mendelian Randomization (MR) analysis

The concept of MR analysis

Given the random distribution of genetic variation during embryonic development and its independence from environmental influences. Mendelian Randomization (MR) analysis demonstrates a reduced susceptibility to reverse causality and confounding issues [18, 19]. Consequently, Mendelian Randomization (MR) analysis is utilized to ascertain single nucleotide polymorphisms (SNPs) linked to 25(OH)D metabolites and sleep disorders, to assess the risk and relationship between 25(OH)D metabolite levels and sleep disorders; 25(OH)D metabolites are serum vitamin D. The MR methodology is delineated in Fig. 2.

Fig. 2

Mendelian Randomization flowchart. MR three major assumptions: (1) the need for genetic variation correlated with the level of 25(OH)D metabolite; (2) this correlation should remain uninfluenced by confounding variables; (3) such genetic variations should exert an impact on sleep disorders solely via the levels of the 25(OH)D metabolite

Figure image at the original source: open the original paper. This file is not included in this text import.

For the exposure dataset of serum vitamin D, we obtained GWAS analysis results involving 441,291 individuals of European descent to generate instrumental variables (IVs) (https://gwas.mrcieu.ac.uk/datasets/ieu-b-4812/). Concerning the GWAS outcome dataset, data pertaining to sleep disorders were procured from a separate GWAS analysis, encompassing 216,454 individuals of European ancestry, including 2628 cases and 213,826 controls (https://gwas.mrcieu.ac.uk/datasets/finn-b-F5_SLEEP/).

Selection of SNPs for MR analysis

Initially, independent genetic variants exhibiting genome-wide significance (p < 5 × 10−8) were chosen from the pertinent datasets as potential instrumental variables correlated with 25-hydroxyvitamin D. Then, those SNPs with linkage disequilibrium (LD) coefficient < 0.001 and distances greater than 10,000 kb were selected as the LD reference group based on the European 1000 genomic dataset [20, 21]. We then screened for confounders by PhenoScanner, and BMI-related SNPs were excluded because BMI was associated with vitamin D concentrations and risk of sleep disturbances [22].

MR analysis

In this Mendelian Randomization (MR) analysis, version 4.3.2 of R software and the TwoSampleMR package were utilized. The primary method used in the analysis was inverse variance weighted (IVW) [23].

Source: Mendelian Randomization (MR) analysis Source: Mendelian Randomization (MR) analysis Source: Mendelian Randomization (MR) analysis

Results: Baseline characteristics of participants

The study encompassed 4,913 participants, with an average age of 34.94 ± 0.35 years; the largest age group was those aged 40 to 50, comprising 36.41%. A significant majority, about 86%, had at least a high school education. The gender distribution was nearly even, with males representing 50.42% and females 49.58%. The average serum vitamin D level among participants was 61.80 nmol/L (Table 1).

Table 1

Descriptions of study individuals’ characteristics

VariablesN = 4913
Age, (years) (%)34.94 ± 0.35
  20 to 291608 (33.25)
  30 to 391578 (30.34)
  40 to 501727 (36.41)
Race/ethnicity (%)
  Mexican American663 (11.34)
  Non-Hispanic white1919 (61.14)
  Non-Hispanic Black1042 (11.56)
  Other race1289 (16.95)
Gender
  Male2464 (50.42)
  Female2449 (49.58)
Married/live with partner
  Yes2846 (60.61)
  No2067 (39.39)
Education level (%)
  Below high school860 (14.17)
  High School or above4053 (85.83)
Poverty income ratio (%)
  Poor1656 (25.53)
  Not poor3257 (74.47)
  Body mass index (kg/m [2])28.69 ± 0.18
Obesity
  Yes1758 (35.34)
  No3155 (64.66)
  Systolic blood pressure (mm Hg)114.1 ± 0.64
  Diastolic blood pressure (mm Hg)69.384 ± 0.43
Smoking (%)
  Yes1152 (22.42)
  No3761 (77.58)
Alcohol use (%)
  Yes3752 (81.20)
  No1157 (18.80)
DM history
  Yes361 (5.75)
  No4548 (94.25)
Hypertension history (%)
  Yes1112 (21.69)
  No3801 (78.31)
  25(OH)D (nmol/L)61.807 ± 1.1925
Sleep disorder

  Yes

  No

690 (13.65)

4223 (86.35)

Continuous variables are presented as mean ± standard error (SE); categorical variables are presented as counts (weighted percentage). Poverty income ratio for not poor was defined as ≥ 1.3 and for poor was defined as < 1.3. Obesity was defined as when body mass index ≥ 30 kg/m2

DM diabetes mellitus, 25(OH)D 25 hydroxy vitamin D3

Source: Baseline characteristics of participants

The relationship between vitamin D and sleep disorders

Results: The relationship between vitamin D and sleep disorders

Serum vitamin D concentrations were divided into quartile portions according to quartiles: Q1 (< 44.99 nmol/L), Q2 (44.99 to 59.83 nmol/L), Q3 (59.84 to 75.99 nmol/L), and Q4 (> 75.99 nmol/L). Table 3 details the odds ratios (ORs) for sleep disorders across these vitamin D concentrations, as per logistic regression analysis. Initially, Model 1, without covariate adjustment, revealed a significant link between lower vitamin D concentrations (Q1, Q2, and Q3) and increased incidence of sleep disorders (p-values: 0.0015, 0.0096, 0.0316, respectively). Model 2, accounting for age, gender, race, and other factors, upheld this association, with significant p-values in the first three quartiles (Q1 < 0.001, Q2 0.0017, and Q3 0.012).

The comprehensive Model 3 showed that participants in Q1 had a notably higher prevalence of sleep disorders compared to those in Q4 (OR 1.52, 95% CI 1.10 to 2.10, trend p = 0.0139). Figure 2, with multivariable-adjusted spline curves, illustrates this relationship. It was found that lower vitamin D concentrations were consistently negatively associated with sleep disorders prevalence (non-linearity p > 0.05).

Table 3

Association between serum vitamin D quartiles and sleep disorders

Model 1Model 2Model 3
OR (95% CI) p-valueOR (95% CI) p-valueOR (95% CI) p-value
Sleep disorders
  Quartile 11.58 (1.21, 2.07)**1.86 (1.39, 2.50)***1.52 (1.10, 2.10)*
  Quartile 21.58 (1.13, 2.21)**1.87 (1.30, 2.70)**1.72 (1.16, 2.56)*
  Quartile 31.35 (1.03, 1.77)*1.45 (1.10, 1.93)*1.45 (1.05, 2.00)*
  Quartile 4RefRefRef
  p for trend0.001840.001150.013879

Model 1, no covariates were adjusted; Model 2, age, sex, and race were adjusted; Model 3, Model 2 plus additional adjustment for the married/live with partner status, education level, poverty income ratios, smoking status, alcohol use, BMI, hypertension, and diabetes were adjusted; a p < 0.05 was considered statistically significant

95% CI 95% confidence interval, OR odds ratio

*p < 0.05, **p < 0.01, and ***p < 0.001

Source: The relationship between vitamin D and sleep disorders

Results: MR of vitamin D and sleep disturbances

The study evaluated the causal effects of genetically predicted vitamin D on sleep disorders using five different Mendelian Randomization (MR) methods. The findings suggested a relationship where higher serum vitamin D concentrations were linked to a reduced risk of sleep disorders (Fig. 3). Specifically, an increase in serum vitamin D concentrations was associated with a 22% decrease in the risk of sleep disorders in high-risk individuals compared to those at low risk. The Inverse Variance Weighted (IVW) method indicated an odds ratio (OR) of 0.78 (95% CI 0.61 to 0.99, p = 0.044) for sleep disturbances, but no significant correlations were found using the other four methods.

These results are illustrated in Figs. 4 and 5.

Fig. 3

Adjusted multivariable spline curves depicting the relationship between serum vitamin D concentrations and sleep disorders, as evaluated through a spline regression model

Figure image at the original source: open the original paper. This file is not included in this text import.
Fig. 4

MR results of serum vitamin D and sleep disturbances

Figure image at the original source: open the original paper. This file is not included in this text import.
Figure5

Scatter plot of serum vitamin D and sleep disturbance

Figure image at the original source: open the original paper. This file is not included in this text import.

Source: MR of vitamin D and sleep disturbances

Results: Single SNP effect analysis

The forest plot in Fig. 6 and the leave-one-out sensitivity analysis in Fig. 7 of this study provide insights into the relationship between vitamin D-related SNPs and sleep disorders. These analyses strengthen the credibility of the study’s conclusions, indicating that individual vitamin D SNPs do not exhibit significant bias in their effects on sleep disorders. This adds robustness to the overall findings regarding the influence of vitamin D on sleep disturbances.

Fig. 6

Leave-one-out analysis of the causal association of serum vitamin D and sleep disturbance

Figure image at the original source: open the original paper. This file is not included in this text import.
Fig. 7

Forest plot of serum vitamin D SNPs associated with sleep disturbances

Figure image at the original source: open the original paper. This file is not included in this text import.

Source: Single SNP effect analysis

Discussion

According to our knowledge, this study is the first of its kind to comprehensively explore the link between serum vitamin D concentrations and the risk of sleep disturbances, utilizing data from large-scale observational studies and genetic data through Mendelian Randomization (MR) analysis. It delves into the relationship and potential causal connection between sleep disturbances and serum vitamin D concentrations. The findings indicate an inverse correlation between serum vitamin D concentrations and sleep disturbances, suggesting a possible negative linear relationship between the two.

This study explores the relationship between serum vitamin D concentrations and sleep disorders, utilizing data from the NHANES 2011 to 2016, focusing on individuals aged 20 to 50. After adjusting for various covariates, a negative correlation was found between serum vitamin D concentrations and the occurrence of sleep disorders. Multivariate adjusted spline regression was used to confirm the negative linear relationship. These findings align with previous studies that emphasize the importance of serum vitamin D in sleep quality [24, 25]. The use of the NHANES database, covering a broad population, lends universal and representative validity to the study.

Understanding the link between vitamin D concentrations and sleep disorders is significant for clinical value and health guidance. Additionally, the study employs large-scale GWAS data to further investigate the causal relationship, with IVW results supporting this connection. Vitamin D receptors (VDRs) are integral to the diverse biological actions of vitamin D, with their presence identified in the central nervous system, including regions implicated in sleep regulation. The contribution of vitamin D to sleep disorders might be attributed to the widespread distribution of its receptors across various brainstem regions, notably within sections of the hypothalamus, recognized for their critical role in governing sleep regulation.

Numerous studies, both domestically and internationally, support the notion that serum vitamin D deficiency leads to sleep disturbances [10, 14]. For instance, a South Korean cross-sectional study found a notable link between vitamin D deficiency and symptoms like daytime sleepiness and reduced sleep duration [26]. Additionally, another study demonstrated that vitamin D supplementation significantly improved sleep duration and decreased sleep disturbances in 20 to 50 year-olds with sleep disorders [14, 27]. In a research involving 81 American patients with sleep disorders, a higher prevalence of daytime sleepiness was observed among those with vitamin D deficiency [28].

Sleep disorders are a very common problem in today’s society and place a significant burden on individuals, families, and society. Our observational studies showed a negative linear association between serum vitamin D insufficiency and sleep disturbances, and MR analyses in this study also showed a negative correlation between serum vitamin D and sleep disturbances. Although the exact mechanism between sleep disturbance and serum vitamin D concentrations is unknown, the underlying mechanisms are as follows. On the one hand, when sleep disorders are seen as a consequence of vitamin D deficiency, one hypothesis is that prostaglandin D2 (PD 2), as a central regulator of sleep, may lead to obstructive sleep apnea.

Vitamin D downregulates cyclooxygenase-2, the rate-controlling enzyme for PD 2 production, in prostate tissue, suggesting that vitamin D insufficiency may lead to an increase in circulating PD 2, leading to sleep disturbance [29, 30]. On the other hand, vitamin D deficiency may lead to musculoskeletal pain, which can lead to poor sleep quality and reduced sleep duration [31, 32]. Sleep quality exhibited a significant enhancement following vitamin D supplementation [27]. Vitamin D receptors (VDRs) play a pivotal role in the multifaceted biological functions of vitamin D, as evidenced by their identification in the central nervous system, encompassing areas involved in sleep regulation.

The involvement of vitamin D in sleep disorders may be ascribed to the extensive dissemination of its receptors throughout diverse brainstem regions, particularly within segments of the hypothalamus, which are acknowledged for their essential role in sleep regulation [33Not reported35]. In addition, animal experiments have shown that in the central nervous system, there are several vitamin D-specific binding sites arranged along neurons, symmetrically distributed with sleep-inducing regions [35].

Our study reinforces the significant negative correlation between serum vitamin D concentrations and sleep disturbances, in line with prior research. Additionally, our MR analysis indicates a significant link between serum vitamin D and sleep disturbances. While a direct causal relationship between vitamin D deficiency and sleep disturbances is not fully clarified, the evidence consistently suggests a negative association across various demographics, including children and older adults [10, 24, 25, 36].

This study corroborates a link between lower vitamin D concentrations and a heightened risk of sleep disorders, emphasizing the significance of vitamin D supplementation in the treatment of these conditions for healthcare professionals [37]. Additionally, the findings underscore the need for public health measures to increase awareness about the adverse effects of vitamin D deficiency.

Our study has several limitations. First, the cross-sectional study and MR analysis involved different ethnic groups, possibly leading to population heterogeneity, and future research should be conducted within the same population. Second, the reliance on self-reported sleep disturbance measures may introduce bias. Third, our data do not differentiate between types of sleep disorders, such as obstructive sleep apnea, insomnia, or delayed sleep phase disorder [38]. Due to the unavailability of direct seasonal data in the NHANES database, we were unable to directly consider the influence of seasonal variations on vitamin D levels in our analysis.

This limitation may have hindered a comprehensive assessment of the relationship between vitamin D levels and seasonal changes. Additionally, other potential links between serum vitamin D and sleep disturbances were not explored. Our study did not conduct reverse research, i.e., investigating whether sleep disturbances lead to vitamin D deficiency. Although the relationship between sleep disturbances and vitamin D levels has been widely discussed, our study did not provide direct evidence to support this hypothesis. It is noteworthy that our study mainly focused on exploring the association between vitamin D levels and sleep disturbances, without considering the potential impact of sleep disturbances on vitamin D levels.

While we controlled for various confounders, residual confounding is possible. Despite these limitations, our study emphasizes the significance of acknowledging the inverse relationship between vitamin D and sleep disorders.

Source: Discussion Source: Discussion Source: Discussion Source: Discussion Source: Discussion Source: Discussion

Results

Baseline characteristics of participants

The study encompassed 4,913 participants, with an average age of 34.94 ± 0.35 years; the largest age group was those aged 40 to 50, comprising 36.41%. A significant majority, about 86%, had at least a high school education. The gender distribution was nearly even, with males representing 50.42% and females 49.58%. The average serum vitamin D level among participants was 61.80 nmol/L (Table 1).

Table 1

Descriptions of study individuals’ characteristics

VariablesN = 4913
Age, (years) (%)34.94 ± 0.35
  20 to 291608 (33.25)
  30 to 391578 (30.34)
  40 to 501727 (36.41)
Race/ethnicity (%)
  Mexican American663 (11.34)
  Non-Hispanic white1919 (61.14)
  Non-Hispanic Black1042 (11.56)
  Other race1289 (16.95)
Gender
  Male2464 (50.42)
  Female2449 (49.58)
Married/live with partner
  Yes2846 (60.61)
  No2067 (39.39)
Education level (%)
  Below high school860 (14.17)
  High School or above4053 (85.83)
Poverty income ratio (%)
  Poor1656 (25.53)
  Not poor3257 (74.47)
  Body mass index (kg/m [2])28.69 ± 0.18
Obesity
  Yes1758 (35.34)
  No3155 (64.66)
  Systolic blood pressure (mm Hg)114.1 ± 0.64
  Diastolic blood pressure (mm Hg)69.384 ± 0.43
Smoking (%)
  Yes1152 (22.42)
  No3761 (77.58)
Alcohol use (%)
  Yes3752 (81.20)
  No1157 (18.80)
DM history
  Yes361 (5.75)
  No4548 (94.25)
Hypertension history (%)
  Yes1112 (21.69)
  No3801 (78.31)
  25(OH)D (nmol/L)61.807 ± 1.1925
Sleep disorder

  Yes

  No

690 (13.65)

4223 (86.35)

Continuous variables are presented as mean ± standard error (SE); categorical variables are presented as counts (weighted percentage). Poverty income ratio for not poor was defined as ≥ 1.3 and for poor was defined as < 1.3. Obesity was defined as when body mass index ≥ 30 kg/m2

DM diabetes mellitus, 25(OH)D 25 hydroxy vitamin D3

Associations between vitamin D and study variables

In the univariate linear regression analysis, significant correlations were observed between serum vitamin D concentrations and various factors including age, race, gender, marital status, education, poverty-income ratio, obesity, and alcohol consumption, as well as histories of diabetes, hypertension, and sleep disturbances. The adjusted multivariate analysis further revealed a significant inverse association between sleep disturbances (β =  − 3.61, 95% CI − 5.89, − 1.34) and serum vitamin D concentrations (p < 0.05), as detailed in Table 2.

Table 2

Linear regression analysis between vitamin D and study variables

UnivariateMultivariate
Variablesβ (95% CI)P valueβ (95% CI)P value
Age (years) (%)
  20 to 29RefRef
  30 to 390.27 (− 2.18, 2.72)0.8320.06 (− 2.18, 2.30)0.960
  40 to 504.77 (1.81, 7.73)0.0043.78 (1.12, 6.43)0.012
Race/ethnicity (%)
  Mexican AmericanRefRef
  Non-Hispanic white19.45 (16.65, 22.25) < 0.00117.36 (14.63, 20.09) < 0.001
  Non-Hispanic Black − 9.44 (− 12.76, − 6.13) < 0.001 − 9.13 (− 12.42, − 5.83) < 0.001
  Other race5.14 (1.92, 8.36)0.0043.74 (0.38, 7.10)0.043
Gender
  MaleRefRef
  Female3.77 (2.09, 5.45) < 0.0014.86 (3.21, 6.51) < 0.001
Married/live with partner
  YesRefRef
  No − 4.54 (− 6.88, − 2.20) < 0.001 − 1.65 (− 3.88, 0.58)0.165
Education level (%)
  Below high schoolRefRef
  High School or above6.34 (3.15, 9.52) < 0.0010.23 (− 2.26, 2.73)0.857
Poverty income ratio (%)
  PoorRef
  Not poor7.76 (5.82, 9.70) < 0.0012.72 (0.46, 4.98)0.030
  Body mass index (kg/m2) − 0.74 (− 0.88, − 0.59) < 0.001Not reportedNot reported
Obesity
  YesRef
  No8.98 (6.78, 11.17) < 0.0017.22 (5.33, 9.11) < 0.001
  Systolic blood pressure (mmHg) − 0.18 (− 0.24, − 0.12) < 0.001Not reportedNot reported
  Diastolic blood pressure (mmHg) − 0.05 (− 0.16, 0.16)0.386Not reportedNot reported
Smoking (%)
  YesRefNot reportedNot reported
  No1.93 (− 0.79, 4.65)0.173Not reportedNot reported
Alcohol use (%)
  YesRefRef
  No − 6.36 (− 9.22, − 3.51) < 0.001 − 2.78 (− 4.74, − 0.81)0.013
DM history
  YesRefRef
  No9.34 (5.71, 13.06) < 0.0013.45 (− 0.11, 7.01)0.074
Hypertension history (%)
  YesRefRef
  No2.87 (0.57, 5.18)0.0210.17 (− 1.71, 2.05)0.861
Sleep disorder
  Yes − 3.81 (− 6.10, − 1.52)0.003 − 3.61 (− 5.89, − 1.34)0.006
  NoRefRef

The parameters adjusted in multivariable linear regression included age, race/ethnicity, gender, married/live with partner status, education level, poverty income ratio, obesity, alcohol use, DM history, hypertension history, and sleep disorder

The relationship between vitamin D and sleep disorders

Serum vitamin D concentrations were divided into quartile portions according to quartiles: Q1 (< 44.99 nmol/L), Q2 (44.99 to 59.83 nmol/L), Q3 (59.84 to 75.99 nmol/L), and Q4 (> 75.99 nmol/L). Table 3 details the odds ratios (ORs) for sleep disorders across these vitamin D concentrations, as per logistic regression analysis. Initially, Model 1, without covariate adjustment, revealed a significant link between lower vitamin D concentrations (Q1, Q2, and Q3) and increased incidence of sleep disorders (p-values: 0.0015, 0.0096, 0.0316, respectively). Model 2, accounting for age, gender, race, and other factors, upheld this association, with significant p-values in the first three quartiles (Q1 < 0.001, Q2 0.0017, and Q3 0.012).

The comprehensive Model 3 showed that participants in Q1 had a notably higher prevalence of sleep disorders compared to those in Q4 (OR 1.52, 95% CI 1.10 to 2.10, trend p = 0.0139). Figure 2, with multivariable-adjusted spline curves, illustrates this relationship. It was found that lower vitamin D concentrations were consistently negatively associated with sleep disorders prevalence (non-linearity p > 0.05).

Table 3

Association between serum vitamin D quartiles and sleep disorders

Model 1Model 2Model 3
OR (95% CI) p-valueOR (95% CI) p-valueOR (95% CI) p-value
Sleep disorders
  Quartile 11.58 (1.21, 2.07)**1.86 (1.39, 2.50)***1.52 (1.10, 2.10)*
  Quartile 21.58 (1.13, 2.21)**1.87 (1.30, 2.70)**1.72 (1.16, 2.56)*
  Quartile 31.35 (1.03, 1.77)*1.45 (1.10, 1.93)*1.45 (1.05, 2.00)*
  Quartile 4RefRefRef
  p for trend0.001840.001150.013879

Model 1, no covariates were adjusted; Model 2, age, sex, and race were adjusted; Model 3, Model 2 plus additional adjustment for the married/live with partner status, education level, poverty income ratios, smoking status, alcohol use, BMI, hypertension, and diabetes were adjusted; a p < 0.05 was considered statistically significant

95% CI 95% confidence interval, OR odds ratio

*p < 0.05, **p < 0.01, and ***p < 0.001

MR of vitamin D and sleep disturbances

The study evaluated the causal effects of genetically predicted vitamin D on sleep disorders using five different Mendelian Randomization (MR) methods. The findings suggested a relationship where higher serum vitamin D concentrations were linked to a reduced risk of sleep disorders (Fig. 3). Specifically, an increase in serum vitamin D concentrations was associated with a 22% decrease in the risk of sleep disorders in high-risk individuals compared to those at low risk. The Inverse Variance Weighted (IVW) method indicated an odds ratio (OR) of 0.78 (95% CI 0.61 to 0.99, p = 0.044) for sleep disturbances, but no significant correlations were found using the other four methods.

These results are illustrated in Figs. 4 and 5.

Fig. 3

Adjusted multivariable spline curves depicting the relationship between serum vitamin D concentrations and sleep disorders, as evaluated through a spline regression model

Figure image at the original source: open the original paper. This file is not included in this text import.
Fig. 4

MR results of serum vitamin D and sleep disturbances

Figure image at the original source: open the original paper. This file is not included in this text import.
Figure5

Scatter plot of serum vitamin D and sleep disturbance

Figure image at the original source: open the original paper. This file is not included in this text import.

Tests for pleiotropy and heterogeneity

The MR-Egger regression intercept in the analysis was − 0.006 with a p-value of 0.243, indicating no significant horizontal pleiotropy, as detailed in Table 4. Furthermore, heterogeneity tests were conducted, and both the MR-Egger and inverse variance-weighted methods yielded p-values greater than 0.05. This suggests the absence of heterogeneity in the data, as presented in Table 5.

Table 4

Polygenic analysis of serum vitamin D genetic variations in sleep disorders in a GWAS dataset

GWAS datasetMR-Egger intercept
Egger_interceptSEp-val
Sleep disorders − 0.0060.0050.243
Table 5

Heterogeneity testing of serum vitamin D genetic variations in sleep disorders in a GWAS dataset

MethodMR-Egger intercept
QQ_dfQ_pval
MR Egger90.589870.375
Inverse variance weighted92.025880.364

Single SNP effect analysis

The forest plot in Fig. 6 and the leave-one-out sensitivity analysis in Fig. 7 of this study provide insights into the relationship between vitamin D-related SNPs and sleep disorders. These analyses strengthen the credibility of the study’s conclusions, indicating that individual vitamin D SNPs do not exhibit significant bias in their effects on sleep disorders. This adds robustness to the overall findings regarding the influence of vitamin D on sleep disturbances.

Fig. 6

Leave-one-out analysis of the causal association of serum vitamin D and sleep disturbance

Figure image at the original source: open the original paper. This file is not included in this text import.
Fig. 7

Forest plot of serum vitamin D SNPs associated with sleep disturbances

Figure image at the original source: open the original paper. This file is not included in this text import.

Source: Results Source: Results Source: Results Source: Results Source: Results Source: Results

Conclusions

Collectively, the findings from this study demonstrate a significant negative correlation between serum vitamin D deficiency and sleep disturbances, as evidenced through both cross-sectional and Mendelian Randomization (MR) analyses. These insights suggest that healthcare professionals should be more vigilant regarding sleep disorders in patients, highlighting the necessity for further comprehensive research to confirm these results and to understand the underlying mechanisms of this association.

Source: Conclusions
Authors’ abstract

Objective

This investigation seeks to examine the association between serum vitamin D concentrations and the prevalence of sleep disorders, additionally elucidating the causal relationship via Mendelian Randomization (MR) analysis.

Materials and methods

This research employed data from the National Health and Nutrition Examination Survey (NHANES) 2011 to 2016, focusing on adults aged 20 to 50 years reporting sleep disorders. The research encompassed 4913 American adults. Weighted multivariable logistic regression models and cubic spline analyses were utilized to evaluate the association between serum vitamin D concentrations and the incidence of sleep disorders. Additionally, a two-sample Mendelian Randomization analysis was performed to evaluate the potential causal link between serum vitamin D concentrations and the risk of sleep disorders.

Results

Within the 2011 to 2016 NHANES cohort of the U.S. population, a notable inverse association was detected between serum vitamin D concentrations and sleep disorders (β =  − 3.81, 95% CI: − 6.10 to − 1.52, p = 0.003). After multivariate adjustments, a higher incidence of sleep disorders was associated with lower vitamin D Concentrations (OR 1.52, 95% CI 1.10 to 2.10, trend p = 0.014). Restricted cubic spline regression analysis indicated a linear association between serum vitamin D concentrations and sleep disorders(non-linearity p > 0.05).

Lastly, the two-sample MR analysis yielded evidence supporting a potential causal connection between serum vitamin D concentrations and sleep disorders, with each unit increase in genetically predicted serum vitamin D reducing the odds ratio to 0.78 (95% CI 0.61 to 0.99, p = 0.044).

Conclusions

These results imply that lower vitamin D concentrations in the population might correlate with a heightened risk of sleep disorders, suggesting the importance of considering vitamin D supplementation when treating sleep disorders.

Supplementary Information

The online version contains supplementary material available at 10.1007/s11325-024-03031-2.

Read the full paper

Introduction

Sleep is a fundamental and essential physiological activity. Insufficient sleep duration, or the presence of diseases that interfere with sleep quality, can lead to sleep disorders [1]. Globally, approximately one billion people suffer from sleep disorders, with the incidence of this condition continually rising, significantly impacting the quality of life for many [2]. Sleep disorders represent a major, under-recognized issue that leads to a variety of other health and societal problems. It has been demonstrated that sleep disorders are closely associated with a range of health concerns, including hypertension, type 2 diabetes, obesity, cardiovascular diseases, and an increased risk of overall mortality [3Not reported6].

Simultaneously, sleep disorders also incur a substantial economic burden. Researchers in Australia have found that in the year 2004 alone, the economic cost of sleep disorders amounted to around 4.5 billion Australian dollars, representing approximately 0.8% of Australia’s Gross Domestic Product (GDP) [7].

Vitamin D is an important steroid hormone that plays a key role in regulating the levels of calcium and phosphorus in the body, which are extremely important for the development of bone tissue [8]. Its deficiency, a widespread health concern, has been linked to multiple acute and chronic health conditions, including sleep disorders [9Not reported12]. Currently, several epidemiological studies have assessed the relationship between vitamin D and sleep disorders. Research indicates that vitamin D deficiency is a common occurrence among patients with sleep disorders, potentially serving as one of the causes of sleep disturbances; furthermore, the study by Majid et al. suggests that supplementation with vitamin D can enhance sleep quality and increase the duration of sleep for subjects suffering from sleep disturbances [13, 14].

However, some scholars have presented a differing view, arguing that there is no correlation between the two [15]. Presently, the relationship between serum vitamin D concentrations and sleep disorders remains inadequately explored and understood.

This study addresses this gap by investigating the potential correlation employing data from the National Health and Nutrition Examination Survey (NHANES) spanning 2011 to 2016. This study utilizes MR analysis, drawing on data from Genome-Wide Association Studies (GWAS) regarding serum vitamin D and sleep disorders, to determine the potential causal influence of serum vitamin D on the risk of sleep disorders.

Materials and methods

Data source

The investigation utilizes data from three successive iterations of the National Health and Nutrition Examination Survey (NHANES), encompassing the timeframes of 2011 to 2012, 2013 to 2014, and 2015 to 2016. The survey encompassed questionnaires, examination data, and laboratory test results and is conducted with the approval of the National Center for Health Statistics (NCHS) Institutional Review Board. Biennial data releases ensure up-to-date information, and participation is contingent on written informed consent from all respondents.

Between 2011 and 2016, the NHANES survey engaged 29,902 participants. Our analysis excluded individuals based on specific criteria: those not within the 20 to 50 age range (20,861 participants), absence of data on 25-hydroxyvitamin D3 (2,389 participants) and other related vitamin D metrics (795 participants), and incomplete information on sleep disorders (944 participants). This resulted in a final sample of 4913 for our study. Figure 1 depicts the selection process.

Fig. 1

Flowchart of participants included in analyses

Figure image at the original source: open the original paper. This file is not included in this text import.

Sleep disorders

Data on sleep disorders were gathered from participants’ responses to a specific query: “Over the last 2 weeks, how often have you been bothered by the following problems: trouble falling or staying asleep, or sleeping too much?” A sleep disorder was identified if the answer was “more than half the days” or “nearly every day.” Conversely, responses of “several days” or “not at all” indicated the absence of a sleep disorder.

Laboratory measures

Ultra-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) was employed for the quantification of 25-hydroxyvitamin D in human serum. The lower limit of detection (LLOD) for 25-hydroxyvitamin D3 was established at 2.23 nmol/L. The comprehensive methodology for this analytical procedure is extensively delineated in other scholarly publications. For values below the LLOD, the calculation employed was the square root of LLOD divided by two (LLOD/√2).

Covariates

Continuous variables in the study encompassed age, body mass index (BMI), along with systolic and diastolic blood pressure. The study categorized variables as follows: Populations or ethnic groups are categorized into four distinct segments: Mexican Americans, non-Hispanic whites, non-Hispanic blacks, and other races. Gender included male and female. Educational attainment is categorized as either incomplete or complete with respect to upper secondary education. In categorizing marital status, the amalgamation of marriage and cohabitation into a single category is contrasted with the distinct classification of being single, divorced, widowed, or separated.

Alcoholism, smoking, poverty-to-income ratio, high blood pressure, and diabetes are categorically classified as “yes” or “no.” Participants’ ages were classified into three categories: 20 to 29, 30 to 39, and 40 to 50. Obesity was defined as a BMI ≥ 30 according to Centers for Disease Control and Prevention (CDC) guidelines. Alcohol status was ascertained based on participants’ responses to the query, which inquired whether they had consumed 12 or more alcoholic drinks in the preceding year. Participants who responded affirmatively were classified as alcohol users, and conversely for those who answered negatively.

Smoking status was assessed using the question: Do you now smoke cigarettes, with respondents answering “Every day” or “Some days” being considered as current smokers. The poverty-income ratio was delineated as ≥ 1.3 for non-poverty status and < 1.3 for poverty status. Each participant had three to four consecutive blood pressure levels taken. Systolic (SBP) and diastolic blood pressure (DBP) values were computed as the average of all extant readings. Hypertension was identified when SBP was ≥ 140 mmHg and DBP was ≥ 90 mmHg [16, 17].

Mendelian Randomization (MR) analysis

The concept of MR analysis

Given the random distribution of genetic variation during embryonic development and its independence from environmental influences. Mendelian Randomization (MR) analysis demonstrates a reduced susceptibility to reverse causality and confounding issues [18, 19]. Consequently, Mendelian Randomization (MR) analysis is utilized to ascertain single nucleotide polymorphisms (SNPs) linked to 25(OH)D metabolites and sleep disorders, to assess the risk and relationship between 25(OH)D metabolite levels and sleep disorders; 25(OH)D metabolites are serum vitamin D. The MR methodology is delineated in Fig. 2.

Fig. 2

Mendelian Randomization flowchart. MR three major assumptions: (1) the need for genetic variation correlated with the level of 25(OH)D metabolite; (2) this correlation should remain uninfluenced by confounding variables; (3) such genetic variations should exert an impact on sleep disorders solely via the levels of the 25(OH)D metabolite

Figure image at the original source: open the original paper. This file is not included in this text import.

For the exposure dataset of serum vitamin D, we obtained GWAS analysis results involving 441,291 individuals of European descent to generate instrumental variables (IVs) (https://gwas.mrcieu.ac.uk/datasets/ieu-b-4812/). Concerning the GWAS outcome dataset, data pertaining to sleep disorders were procured from a separate GWAS analysis, encompassing 216,454 individuals of European ancestry, including 2628 cases and 213,826 controls (https://gwas.mrcieu.ac.uk/datasets/finn-b-F5_SLEEP/).

Selection of SNPs for MR analysis

Initially, independent genetic variants exhibiting genome-wide significance (p < 5 × 10−8) were chosen from the pertinent datasets as potential instrumental variables correlated with 25-hydroxyvitamin D. Then, those SNPs with linkage disequilibrium (LD) coefficient < 0.001 and distances greater than 10,000 kb were selected as the LD reference group based on the European 1000 genomic dataset [20, 21]. We then screened for confounders by PhenoScanner, and BMI-related SNPs were excluded because BMI was associated with vitamin D concentrations and risk of sleep disturbances [22].

MR analysis

In this Mendelian Randomization (MR) analysis, version 4.3.2 of R software and the TwoSampleMR package were utilized. The primary method used in the analysis was inverse variance weighted (IVW) [23].

Statistical analysis

Continuous variables were reported as weighted means accompanied by standard errors, while categorical variables were presented in terms of frequencies and corresponding weighted percentages.

Initially, the baseline characteristics of the participants were delineated. Subsequently, weighted univariate and multivariate linear regression analyses were conducted to explore the relationship between vitamin D concentrations and various study variables, with the objective of identifying factors that influence vitamin D concentrations. Thirdly, the logistic regression model was employed to compute the adjusted odds ratios (OR) and 95% confidence intervals (CI) pertaining to the association between vitamin D concentrations and sleep disorders. Three covariate models were constructed as follows: Model 1 without adjustment for variables.

In Model 2, adjustments were made for age, sex, and race/ethnicity as categorical variables. Model 3 was adjusted for all variables, while also assessing the trend across quartiles of vitamin D. To determine the linearity of the association between vitamin D concentrations and sleep disorders, restricted cubic spline regression was utilized. All statistical analyses, encompassing the ones delineated herein, were executed utilizing R software, version 4.3.2. For each analysis, a p-value of less than 0.05 was deemed to be statistically significant.

Results

Baseline characteristics of participants

The study encompassed 4,913 participants, with an average age of 34.94 ± 0.35 years; the largest age group was those aged 40 to 50, comprising 36.41%. A significant majority, about 86%, had at least a high school education. The gender distribution was nearly even, with males representing 50.42% and females 49.58%. The average serum vitamin D level among participants was 61.80 nmol/L (Table 1).

Table 1

Descriptions of study individuals’ characteristics

VariablesN = 4913
Age, (years) (%)34.94 ± 0.35
  20 to 291608 (33.25)
  30 to 391578 (30.34)
  40 to 501727 (36.41)
Race/ethnicity (%)
  Mexican American663 (11.34)
  Non-Hispanic white1919 (61.14)
  Non-Hispanic Black1042 (11.56)
  Other race1289 (16.95)
Gender
  Male2464 (50.42)
  Female2449 (49.58)
Married/live with partner
  Yes2846 (60.61)
  No2067 (39.39)
Education level (%)
  Below high school860 (14.17)
  High School or above4053 (85.83)
Poverty income ratio (%)
  Poor1656 (25.53)
  Not poor3257 (74.47)
  Body mass index (kg/m [2])28.69 ± 0.18
Obesity
  Yes1758 (35.34)
  No3155 (64.66)
  Systolic blood pressure (mm Hg)114.1 ± 0.64
  Diastolic blood pressure (mm Hg)69.384 ± 0.43
Smoking (%)
  Yes1152 (22.42)
  No3761 (77.58)
Alcohol use (%)
  Yes3752 (81.20)
  No1157 (18.80)
DM history
  Yes361 (5.75)
  No4548 (94.25)
Hypertension history (%)
  Yes1112 (21.69)
  No3801 (78.31)
  25(OH)D (nmol/L)61.807 ± 1.1925
Sleep disorder

  Yes

  No

690 (13.65)

4223 (86.35)

Continuous variables are presented as mean ± standard error (SE); categorical variables are presented as counts (weighted percentage). Poverty income ratio for not poor was defined as ≥ 1.3 and for poor was defined as < 1.3. Obesity was defined as when body mass index ≥ 30 kg/m2

DM diabetes mellitus, 25(OH)D 25 hydroxy vitamin D3

Associations between vitamin D and study variables

In the univariate linear regression analysis, significant correlations were observed between serum vitamin D concentrations and various factors including age, race, gender, marital status, education, poverty-income ratio, obesity, and alcohol consumption, as well as histories of diabetes, hypertension, and sleep disturbances. The adjusted multivariate analysis further revealed a significant inverse association between sleep disturbances (β =  − 3.61, 95% CI − 5.89, − 1.34) and serum vitamin D concentrations (p < 0.05), as detailed in Table 2.

Table 2

Linear regression analysis between vitamin D and study variables

UnivariateMultivariate
Variablesβ (95% CI)P valueβ (95% CI)P value
Age (years) (%)
  20 to 29RefRef
  30 to 390.27 (− 2.18, 2.72)0.8320.06 (− 2.18, 2.30)0.960
  40 to 504.77 (1.81, 7.73)0.0043.78 (1.12, 6.43)0.012
Race/ethnicity (%)
  Mexican AmericanRefRef
  Non-Hispanic white19.45 (16.65, 22.25) < 0.00117.36 (14.63, 20.09) < 0.001
  Non-Hispanic Black − 9.44 (− 12.76, − 6.13) < 0.001 − 9.13 (− 12.42, − 5.83) < 0.001
  Other race5.14 (1.92, 8.36)0.0043.74 (0.38, 7.10)0.043
Gender
  MaleRefRef
  Female3.77 (2.09, 5.45) < 0.0014.86 (3.21, 6.51) < 0.001
Married/live with partner
  YesRefRef
  No − 4.54 (− 6.88, − 2.20) < 0.001 − 1.65 (− 3.88, 0.58)0.165
Education level (%)
  Below high schoolRefRef
  High School or above6.34 (3.15, 9.52) < 0.0010.23 (− 2.26, 2.73)0.857
Poverty income ratio (%)
  PoorRef
  Not poor7.76 (5.82, 9.70) < 0.0012.72 (0.46, 4.98)0.030
  Body mass index (kg/m2) − 0.74 (− 0.88, − 0.59) < 0.001Not reportedNot reported
Obesity
  YesRef
  No8.98 (6.78, 11.17) < 0.0017.22 (5.33, 9.11) < 0.001
  Systolic blood pressure (mmHg) − 0.18 (− 0.24, − 0.12) < 0.001Not reportedNot reported
  Diastolic blood pressure (mmHg) − 0.05 (− 0.16, 0.16)0.386Not reportedNot reported
Smoking (%)
  YesRefNot reportedNot reported
  No1.93 (− 0.79, 4.65)0.173Not reportedNot reported
Alcohol use (%)
  YesRefRef
  No − 6.36 (− 9.22, − 3.51) < 0.001 − 2.78 (− 4.74, − 0.81)0.013
DM history
  YesRefRef
  No9.34 (5.71, 13.06) < 0.0013.45 (− 0.11, 7.01)0.074
Hypertension history (%)
  YesRefRef
  No2.87 (0.57, 5.18)0.0210.17 (− 1.71, 2.05)0.861
Sleep disorder
  Yes − 3.81 (− 6.10, − 1.52)0.003 − 3.61 (− 5.89, − 1.34)0.006
  NoRefRef

The parameters adjusted in multivariable linear regression included age, race/ethnicity, gender, married/live with partner status, education level, poverty income ratio, obesity, alcohol use, DM history, hypertension history, and sleep disorder

The relationship between vitamin D and sleep disorders

Serum vitamin D concentrations were divided into quartile portions according to quartiles: Q1 (< 44.99 nmol/L), Q2 (44.99 to 59.83 nmol/L), Q3 (59.84 to 75.99 nmol/L), and Q4 (> 75.99 nmol/L). Table 3 details the odds ratios (ORs) for sleep disorders across these vitamin D concentrations, as per logistic regression analysis. Initially, Model 1, without covariate adjustment, revealed a significant link between lower vitamin D concentrations (Q1, Q2, and Q3) and increased incidence of sleep disorders (p-values: 0.0015, 0.0096, 0.0316, respectively). Model 2, accounting for age, gender, race, and other factors, upheld this association, with significant p-values in the first three quartiles (Q1 < 0.001, Q2 0.0017, and Q3 0.012).

The comprehensive Model 3 showed that participants in Q1 had a notably higher prevalence of sleep disorders compared to those in Q4 (OR 1.52, 95% CI 1.10 to 2.10, trend p = 0.0139). Figure 2, with multivariable-adjusted spline curves, illustrates this relationship. It was found that lower vitamin D concentrations were consistently negatively associated with sleep disorders prevalence (non-linearity p > 0.05).

Table 3

Association between serum vitamin D quartiles and sleep disorders

Model 1Model 2Model 3
OR (95% CI) p-valueOR (95% CI) p-valueOR (95% CI) p-value
Sleep disorders
  Quartile 11.58 (1.21, 2.07)**1.86 (1.39, 2.50)***1.52 (1.10, 2.10)*
  Quartile 21.58 (1.13, 2.21)**1.87 (1.30, 2.70)**1.72 (1.16, 2.56)*
  Quartile 31.35 (1.03, 1.77)*1.45 (1.10, 1.93)*1.45 (1.05, 2.00)*
  Quartile 4RefRefRef
  p for trend0.001840.001150.013879

Model 1, no covariates were adjusted; Model 2, age, sex, and race were adjusted; Model 3, Model 2 plus additional adjustment for the married/live with partner status, education level, poverty income ratios, smoking status, alcohol use, BMI, hypertension, and diabetes were adjusted; a p < 0.05 was considered statistically significant

95% CI 95% confidence interval, OR odds ratio

*p < 0.05, **p < 0.01, and ***p < 0.001

MR of vitamin D and sleep disturbances

The study evaluated the causal effects of genetically predicted vitamin D on sleep disorders using five different Mendelian Randomization (MR) methods. The findings suggested a relationship where higher serum vitamin D concentrations were linked to a reduced risk of sleep disorders (Fig. 3). Specifically, an increase in serum vitamin D concentrations was associated with a 22% decrease in the risk of sleep disorders in high-risk individuals compared to those at low risk. The Inverse Variance Weighted (IVW) method indicated an odds ratio (OR) of 0.78 (95% CI 0.61 to 0.99, p = 0.044) for sleep disturbances, but no significant correlations were found using the other four methods.

These results are illustrated in Figs. 4 and 5.

Fig. 3

Adjusted multivariable spline curves depicting the relationship between serum vitamin D concentrations and sleep disorders, as evaluated through a spline regression model

Figure image at the original source: open the original paper. This file is not included in this text import.
Fig. 4

MR results of serum vitamin D and sleep disturbances

Figure image at the original source: open the original paper. This file is not included in this text import.
Figure5

Scatter plot of serum vitamin D and sleep disturbance

Figure image at the original source: open the original paper. This file is not included in this text import.

Tests for pleiotropy and heterogeneity

The MR-Egger regression intercept in the analysis was − 0.006 with a p-value of 0.243, indicating no significant horizontal pleiotropy, as detailed in Table 4. Furthermore, heterogeneity tests were conducted, and both the MR-Egger and inverse variance-weighted methods yielded p-values greater than 0.05. This suggests the absence of heterogeneity in the data, as presented in Table 5.

Table 4

Polygenic analysis of serum vitamin D genetic variations in sleep disorders in a GWAS dataset

GWAS datasetMR-Egger intercept
Egger_interceptSEp-val
Sleep disorders − 0.0060.0050.243
Table 5

Heterogeneity testing of serum vitamin D genetic variations in sleep disorders in a GWAS dataset

MethodMR-Egger intercept
QQ_dfQ_pval
MR Egger90.589870.375
Inverse variance weighted92.025880.364

Single SNP effect analysis

The forest plot in Fig. 6 and the leave-one-out sensitivity analysis in Fig. 7 of this study provide insights into the relationship between vitamin D-related SNPs and sleep disorders. These analyses strengthen the credibility of the study’s conclusions, indicating that individual vitamin D SNPs do not exhibit significant bias in their effects on sleep disorders. This adds robustness to the overall findings regarding the influence of vitamin D on sleep disturbances.

Fig. 6

Leave-one-out analysis of the causal association of serum vitamin D and sleep disturbance

Figure image at the original source: open the original paper. This file is not included in this text import.
Fig. 7

Forest plot of serum vitamin D SNPs associated with sleep disturbances

Figure image at the original source: open the original paper. This file is not included in this text import.

Discussion

According to our knowledge, this study is the first of its kind to comprehensively explore the link between serum vitamin D concentrations and the risk of sleep disturbances, utilizing data from large-scale observational studies and genetic data through Mendelian Randomization (MR) analysis. It delves into the relationship and potential causal connection between sleep disturbances and serum vitamin D concentrations. The findings indicate an inverse correlation between serum vitamin D concentrations and sleep disturbances, suggesting a possible negative linear relationship between the two.

This study explores the relationship between serum vitamin D concentrations and sleep disorders, utilizing data from the NHANES 2011 to 2016, focusing on individuals aged 20 to 50. After adjusting for various covariates, a negative correlation was found between serum vitamin D concentrations and the occurrence of sleep disorders. Multivariate adjusted spline regression was used to confirm the negative linear relationship. These findings align with previous studies that emphasize the importance of serum vitamin D in sleep quality [24, 25]. The use of the NHANES database, covering a broad population, lends universal and representative validity to the study.

Understanding the link between vitamin D concentrations and sleep disorders is significant for clinical value and health guidance. Additionally, the study employs large-scale GWAS data to further investigate the causal relationship, with IVW results supporting this connection. Vitamin D receptors (VDRs) are integral to the diverse biological actions of vitamin D, with their presence identified in the central nervous system, including regions implicated in sleep regulation. The contribution of vitamin D to sleep disorders might be attributed to the widespread distribution of its receptors across various brainstem regions, notably within sections of the hypothalamus, recognized for their critical role in governing sleep regulation.

Numerous studies, both domestically and internationally, support the notion that serum vitamin D deficiency leads to sleep disturbances [10, 14]. For instance, a South Korean cross-sectional study found a notable link between vitamin D deficiency and symptoms like daytime sleepiness and reduced sleep duration [26]. Additionally, another study demonstrated that vitamin D supplementation significantly improved sleep duration and decreased sleep disturbances in 20 to 50 year-olds with sleep disorders [14, 27]. In a research involving 81 American patients with sleep disorders, a higher prevalence of daytime sleepiness was observed among those with vitamin D deficiency [28].

Sleep disorders are a very common problem in today’s society and place a significant burden on individuals, families, and society. Our observational studies showed a negative linear association between serum vitamin D insufficiency and sleep disturbances, and MR analyses in this study also showed a negative correlation between serum vitamin D and sleep disturbances. Although the exact mechanism between sleep disturbance and serum vitamin D concentrations is unknown, the underlying mechanisms are as follows. On the one hand, when sleep disorders are seen as a consequence of vitamin D deficiency, one hypothesis is that prostaglandin D2 (PD 2), as a central regulator of sleep, may lead to obstructive sleep apnea.

Vitamin D downregulates cyclooxygenase-2, the rate-controlling enzyme for PD 2 production, in prostate tissue, suggesting that vitamin D insufficiency may lead to an increase in circulating PD 2, leading to sleep disturbance [29, 30]. On the other hand, vitamin D deficiency may lead to musculoskeletal pain, which can lead to poor sleep quality and reduced sleep duration [31, 32]. Sleep quality exhibited a significant enhancement following vitamin D supplementation [27]. Vitamin D receptors (VDRs) play a pivotal role in the multifaceted biological functions of vitamin D, as evidenced by their identification in the central nervous system, encompassing areas involved in sleep regulation.

The involvement of vitamin D in sleep disorders may be ascribed to the extensive dissemination of its receptors throughout diverse brainstem regions, particularly within segments of the hypothalamus, which are acknowledged for their essential role in sleep regulation [33Not reported35]. In addition, animal experiments have shown that in the central nervous system, there are several vitamin D-specific binding sites arranged along neurons, symmetrically distributed with sleep-inducing regions [35].

Our study reinforces the significant negative correlation between serum vitamin D concentrations and sleep disturbances, in line with prior research. Additionally, our MR analysis indicates a significant link between serum vitamin D and sleep disturbances. While a direct causal relationship between vitamin D deficiency and sleep disturbances is not fully clarified, the evidence consistently suggests a negative association across various demographics, including children and older adults [10, 24, 25, 36].

This study corroborates a link between lower vitamin D concentrations and a heightened risk of sleep disorders, emphasizing the significance of vitamin D supplementation in the treatment of these conditions for healthcare professionals [37]. Additionally, the findings underscore the need for public health measures to increase awareness about the adverse effects of vitamin D deficiency.

Our study has several limitations. First, the cross-sectional study and MR analysis involved different ethnic groups, possibly leading to population heterogeneity, and future research should be conducted within the same population. Second, the reliance on self-reported sleep disturbance measures may introduce bias. Third, our data do not differentiate between types of sleep disorders, such as obstructive sleep apnea, insomnia, or delayed sleep phase disorder [38]. Due to the unavailability of direct seasonal data in the NHANES database, we were unable to directly consider the influence of seasonal variations on vitamin D levels in our analysis.

This limitation may have hindered a comprehensive assessment of the relationship between vitamin D levels and seasonal changes. Additionally, other potential links between serum vitamin D and sleep disturbances were not explored. Our study did not conduct reverse research, i.e., investigating whether sleep disturbances lead to vitamin D deficiency. Although the relationship between sleep disturbances and vitamin D levels has been widely discussed, our study did not provide direct evidence to support this hypothesis. It is noteworthy that our study mainly focused on exploring the association between vitamin D levels and sleep disturbances, without considering the potential impact of sleep disturbances on vitamin D levels.

While we controlled for various confounders, residual confounding is possible. Despite these limitations, our study emphasizes the significance of acknowledging the inverse relationship between vitamin D and sleep disorders.

Conclusions

Collectively, the findings from this study demonstrate a significant negative correlation between serum vitamin D deficiency and sleep disturbances, as evidenced through both cross-sectional and Mendelian Randomization (MR) analyses. These insights suggest that healthcare professionals should be more vigilant regarding sleep disorders in patients, highlighting the necessity for further comprehensive research to confirm these results and to understand the underlying mechanisms of this association.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (18.5 KB)

Supplement file at the original source: open the original paper. This file is not included in this text import.

Abbreviations

NHANES

National Health and Nutrition Examination Survey

MR

Mendelian Randomization

OR

Odds ratio

CI

Confidence interval

GWAS

Genome-Wide Association Studies

UHPLC-MS/MS

Ultra-performance liquid chromatography-tandem mass spectrometry

LLOD

Lower limit of detection

BMI

Body mass index

NCHS

National Center for Health Statistics

CDC

Centers for Disease Control and Prevention

DBP

Diastolic blood pressure

SBP

Systolic blood pressure

IRB

Institutional Review Board

SNPs

Single-nucleotide polymorphisms

IVs

Instrumental variables

LD

Linkage disequilibrium

IVW

Inverse variance weighted

VDRs

Vitamin D receptors

PD2

Prostaglandin D2

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Junjie Jiang and Hanyu Tan contributed equally to this work.

Author contribution

JJJ is responsible for writing the manuscript; THY is in charge of proofreading and refining the manuscript’s wording. XZF, LJ, and ZS contributed to data collection and statistical analyses. JJJ, THY, and HT designed the study and oversaw all clinical aspects of study conduct and manuscript preparation. All authors contributed to the article and approved the submitted version.

Funding

No funding was received for this research.

Data availability

The data used in this study are available on the National Health and Nutrition Examination Survey website: https://www.cdc.gov/nchs/nhanes/index.htm. All the data used in this study had been publicly available.

Declarations

Ethics approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Conflict of interest

The authors declare no competing interests.

References

1. Hillman DR, Lack LC (2013) Public health implications of sleep loss: the community burden. Med J Aust 199:S7-10. 10.5694/mja13.10620 24138358 10.5694/mja13.10620
2. Benjafield AV et al (2019) Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med 7:687 to 698. 10.1016/S2213-2600(19)30198-5 31300334 10.1016/S2213-2600(19)30198-5 PMC7007763
3. Vgontzas AN, Liao D, Bixler EO (2009) Insomnia with objective short sleep duration is associated with a high risk for hypertension. Sleep 32(4):491 to 497. 10.1093/sleep/32.4.491 10.1093/sleep/32.4.491 PMC2663863 19413143
4. Spiegel K, Knutson K, Leproult R, Tasali E, Van Cauter E (2005) Sleep loss: a novel risk factor for insulin resistance and type 2 diabetes. J Appl Physiol 1985(99):2008 to 2019. 10.1152/japplphysiol.00660.2005 10.1152/japplphysiol.00660.2005 16227462
5. Sabanayagam C, Shankar A (2010) Sleep duration and cardiovascular disease: results from the National Health Interview Survey. Sleep 33(8):1037 to 1042. 10.1093/sleep/33.8.1037 10.1093/sleep/33.8.1037 PMC2910533 20815184
6. Grandner MA, Hale L, Moore M, Patel NP (2010) Mortality associated with short sleep duration: the evidence, the possible mechanisms, and the future. Sleep Med Rev 14:191 to 203. 10.1016/j.smrv.2009.07.006 19932976 10.1016/j.smrv.2009.07.006 PMC2856739
7. Hillman DR, Murphy AS, Pezzullo L (2006) The economic cost of sleep disorders. Sleep 29(3):299 to 305. 10.1093/sleep/29.3.299 10.1093/sleep/29.3.299 16553015
8. Giustina A et al (2020) Consensus statement from 2nd International Conference on Controversies in Vitamin D 21:89 to 116. 10.1007/s11154-019-09532-w 10.1007/s11154-019-09532-w PMC7113202 32180081
9. Hossein-nezhad A, Holick MF (2013) Vitamin D for health: a global perspective. Mayo Clin Proc 88:720 to 755. 10.1016/j.mayocp.2013.05.011 23790560 10.1016/j.mayocp.2013.05.011 PMC3761874
10. Gao Q et al (2018) The Association between vitamin D deficiency and sleep disorders: a systematic review and meta-analysis. Nutrients 10. 10.3390/nu10101395 10.3390/nu10101395 PMC6213953 30275418
11. Holick MF (2007) Vitamin D deficiency. N Engl J Med 357:266 to 281. 10.1056/NEJMra070553 10.1056/NEJMra070553 17634462
12. Holick MF, Chen TC (2008) Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr 87:1080S: 1086S. 10.1093/ajcn/87.4.1080S 10.1093/ajcn/87.4.1080S 18400738
13. McCarty DE, Chesson Jr AL, Jain SK, Marino AA (2014) The link between vitamin D metabolism and sleep medicine. Sleep Med Rev 18:311 to 319. 10.1016/j.smrv.2013.07.001 10.1016/j.smrv.2013.07.001 24075129
14. Majid MS, Ahmad HS, Bizhan H, Hosein HZM, Mohammad A (2018) The effect of vitamin D supplement on the score and quality of sleep in 20 to 50 year-old people with sleep disorders compared with control group. Nutr Neurosci 21:511 to 519. 10.1080/1028415X.2017.1317395 28475473 10.1080/1028415X.2017.1317395
15. Gunduz S et al (2016) Sleep deprivation in the last trimester of pregnancy and inadequate vitamin D: Is there a relationship? 79:34 to 38. 10.1016/j.jcma.2015.06.017 10.1016/j.jcma.2015.06.017 26391786
16. Muntner P et al (2020) Trends in blood pressure control among US adults with hypertension, 1999 to 2000 to 2017 to 2018. 324:1190 to 1200. 10.1001/jama.2020.14545 10.1001/jama.2020.14545 PMC7489367 32902588
17. Chobanian AV et al (2003) Seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. 42:1206 to 1252. 10.1161/01.HYP.0000107251.49515.c2 10.1161/01.HYP.0000107251.49515.c2 14656957
18. Didelez V Sheehan N (2007) Mendelian randomization as an instrumental variable approach to causal inference. Stat Methods Med Res 16:309 to 330.10.1177/0962280206077743 10.1177/0962280206077743 17715159
19. Sekula P, Fabiola Del Greco M, Pattaro C, Köttgen A (2016) Mendelian randomization as an approach to assess causality using observational data. J Am Soc Nephro 27:3253. 10.1681/ASN.2016010098 10.1681/ASN.2016010098 PMC5084898 27486138
20. Myers TA, Chanock SJ, Machiela MJ (2020) LDlinkR: an R package for rapidly calculating linkage disequilibrium statistics in diverse populations. Front Genet 11:157. 10.3389/fgene.2020.00157 10.3389/fgene.2020.00157 PMC7059597 32180801
21. Machiela MJ, Chanock, SJ (2015) LDlink: a web-based application for exploring population-specific haplotype structure and linking correlated alleles of possible functional variants. Bioinformatics 31:3555 to 3557. 10.1093/bioinformatics/btv402 10.1093/bioinformatics/btv402 PMC4626747 26139635
22. KS Vimaleswaran et al (2013) Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts 10:e1001383. 10.1371/journal.pmed.1001383 10.1371/journal.pmed.1001383 PMC3564800 23393431
23. Verbanck M, Chen CY, Neale B Do R (2018) Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases. Nature Genetics 50:693 to 698. 10.1038/s41588-018-0099-7 10.1038/s41588-018-0099-7 PMC6083837 29686387
24. Prono F, Bernardi K, Ferri R, Bruni O (2022) The role of vitamin D in sleep disorders of children and adolescents: a systematic review. Int J Mol Sci 23. 10.3390/ijms23031430 10.3390/ijms23031430 PMC8835880 35163353
25. Yan S et al (2020) A meta-analysis: does vitamin D play a promising role in sleep disorders? Food Sci Nutr 8:5696 to 5709. 10.1002/fsn3.1867 33133571 10.1002/fsn3.1867 PMC7590291
26. Jung YS et al (2017) The relationship between serum vitamin D levels and sleep quality in fixed day indoor field workers in the electronics manufacturing industry in Korea. Ann Occup Environ Med 29:25. 10.1186/s40557-017-0187-7 28652922 10.1186/s40557-017-0187-7 PMC5482959
27. Huang W, Shah S, Long Q, Crankshaw AK, Tangpricha V (2013) Improvement of pain, sleep, and quality of life in chronic pain patients with vitamin D supplementation. Clin J Pain 29:341 to 347. 10.1097/AJP.0b013e318255655d 10.1097/AJP.0b013e318255655d 22699141
28. McCarty DE, Reddy A, Keigley Q Kim PY, Marino A (2012) Vitamin D race and excessive daytime sleepiness. 8:693 to 697. 10.5664/jcsm.2266 10.5664/jcsm.2266 PMC3501666 23243403
29. McCarty DE, Chesson AL Jr, Jain SK, Marino AA (2014) The link between vitamin D metabolism and sleep medicine. Sleep Med Rev 18:311 to 319. 10.1016/j.smrv.2013.07.001 24075129 10.1016/j.smrv.2013.07.001
30. Feldman D et al (2007) Vitamin D inhibition of the prostaglandin pathway as therapy for prostate cancer. Nutr Rev 65:113 to 115. 10.1301/nr.2007.aug.S113-S115 10.1301/nr.2007.aug.S113-S115 17867384
31. Lee P, Greenfield JR, Campbell LV (2009) Vitamin D insufficiency: a novel mechanism of statin-induced myalgia? Clin Endocrinol (Oxf) 71:154 to 155. 10.1111/j.1365-2265.2008.03448.x 19178510 10.1111/j.1365-2265.2008.03448.x
32. Okura K et al (2008) Comparison of sleep variables between chronic widespread musculoskeletal pain, insomnia, periodic leg movements syndrome and control subjects in a clinical sleep medicine practice. Sleep Med 9:352 to 361. 10.1016/j.sleep.2007.07.007 17804292 10.1016/j.sleep.2007.07.007
33. R Balden A Selvamani FJE Sohrabji (2012) Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats 153:2420-2435. 10.1210/en.2011-1783 10.1210/en.2011-1783 PMC3339639 22408173
34. Zakon HH (1998) The effects of steroid hormones on electrical activity of excitable cells. Trends Neurosci 21:202 to 207. 10.1016/s0166-2236(97)01209-5 10.1016/s0166-2236(97)01209-5 9610884
35. Stumpf W, O’Brien L (1987) 1, 25 (OH) 2 vitamin D3 sites of action in the brain: an autoradiographic study. Histochemistry 87:393 to 406. 10.1007/BF00496810 10.1007/BF00496810 2828283
36. Eshaghi S et al (2020) The effect of aerobic training and vitamin D supplements on the neurocognitive functions of elderly women with sleep disorders 51:727-734. 10.1080/09291016.2019.1579884
37. MJN Abboud (2022) Vitamin D supplementation and sleep: a systematic review and meta-analysis of intervention studies 14:1076. 10.3390/nu14051076 10.3390/nu14051076 PMC8912284 35268051
38. MJJN Thorpy (2012) Classification of sleep disorders 9:687-701. 10.1007/s13311-012-0145-6 10.1007/s13311-012-0145-6 PMC3480567 22976557
Publication and source details

Original title: Serum vitamin D concentrations and sleep disorders: insights from NHANES 2011 to 2016 and Mendelian Randomization analysis

Junjie Jiang; Hanyu Tan; Zhongfang Xia; Jun Li; Shuang Zhou; Tao Huang

Sleep & Breathing = Schlaf & Atmung · 2024

© The Author(s) 20242024https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T04:09:11.036293+00:00

DOI: 10.1007/s11325-024-03031-2 · PMC11303418